BIOREACTOR WITH FREEZE-THAW CAPABILITIES TO ENHANCE PRODUCT RECOVERY AND RELATED METHODS
20210180001 · 2021-06-17
Inventors
- José Castillo (Brussels, BE)
- Bastien Mairesse (Uccle, BE)
- Sebastien Jean-Pierre Michel Rodriguez (Ecaussines-Lalaing, BE)
Cpc classification
International classification
Abstract
An apparatus is provided for bioprocessing, such as for culturing cells. The apparatus includes a bioreactor with a chamber having cells and a chamber for) temperature regulation of the cells. In some embodiments, a freezer is connected to the bioreactor for freezing the cells in the chamber, and a heater may also be provided for actively thawing the cells. Related methods are also disclosed.
Claims
1. A bioreactor, comprising: a first chamber having cells; and a second chamber providing temperature control of the cells in the first chamber.
2. The bioreactor of claim 1, wherein the second chamber comprises a freezer connected to the bioreactor.
3. The bioreactor of claim 1, wherein the second chamber comprises a jacket surrounding the first chamber.
4. The bioreactor of claim 3, wherein the jacket comprises an inlet and an outlet for receiving a chilled fluid.
5. The bioreactor of claim 3, wherein the jacket comprises a pipe for circulating a chilled fluid within the jacket.
6. The bioreactor of claim 5, wherein the jacket includes a thermally conductive fluid.
7. The bioreactor of claim 3, wherein the jacket comprises a bladder including a chilled fluid for contacting a wall of the first chamber.
8. The bioreactor of claim 7, wherein the bladder comprises an inlet and an outlet.
9. The bioreactor of claim 2, wherein the jacket comprises a removable sleeve.
10. The bioreactor of claim 2, wherein the freezer comprises a chiller for chilling a fluid and a pump for circulating the fluid.
11. The bioreactor of claim 1, further comprising a heater for heating the bioreactor.
12. The bioreactor of claim 11, wherein the heater is adapted for at least partially receiving the bioreactor.
13. The bioreactor of claim 11, wherein the heater comprises a conductive block having a heating element applied thereto.
14. The bioreactor of claim 11, wherein the heater is integrated into the bioreactor.
15. The bioreactor of claim 14, wherein the heater is located at least partially within a wall of the bioreactor.
16. The bioreactor of claim 15, wherein the heater comprises a wire within the wall and connected to a power supply.
17. The bioreactor of claim 15, wherein the heater comprises a passage within the wall and connected to a source of heated fluid.
18. The bioreactor of claim 1, wherein the bioreactor comprises a modular bioreactor.
19. The bioreactor of claim 1, wherein the bioreactor comprises a structured fixed bed.
20.-43. (canceled)
44. An apparatus, comprising: a bioreactor including a chamber having cells; and a freezer connected to the bioreactor for freezing the cells in the chamber.
45.-77. (canceled)
Description
BRIEF DESCRIPTION OF THE DRAWING FIGURES
[0027] The novel features of the disclosure are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present disclosure will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
DETAILED DESCRIPTION
[0038] Reference is now made to
[0039] Within the interior compartment formed by the bioreactor housing 112, several compartments or chambers may be provided for transmitting a flow of fluid or gasses throughout the bioreactor 100. As indicated in
[0040] In some embodiments, fluid exiting the chamber 120 is passed to a chamber 124 on one (upper) side of the bed 122, where the fluid is exposed to a gas (such as oxygen or nitrogen). In some embodiments, fluid may then flow radially inwardly to a central return chamber 126. In some embodiments, the central return chamber can be columnar in nature and may be formed by an imperforate conduit or tube 128 or rather formed by the central opening of the structured spiral bed. In some embodiments, the chamber 126 returns the fluid to the first chamber 116 (return arrow R) for recirculation through the bioreactor 100, such that a continuous loop results (“bottom to top” in this version). In some embodiments, a sensor, for example a temperature probe or sensor T may also be provided for sensing the temperature of the fluid in the chamber 126. In some embodiments, additional sensors (such as, for example, pH, oxygen, dissolved oxygen, temperature) may also be provided at a location before the fluid enters (or re-enters) the chamber 116.
[0041]
[0042] A second embodiment of a bioreactor 200 is described with reference to
[0043] In some embodiments, and as perhaps best understood from
[0044] Two intermediate parts 250a, 250b are shown as being stacked, with a peripheral connector (groove 254) of the first (lower) part 250a engaging a corresponding connector (tongue 252) of the second (upper) part 250b. As can be appreciated from
[0045] In some embodiments, the first or lower intermediate part 250a may also include openings, such as elongated arcuate slots 264, which at least partially receive connectors, of the base part 230, such as upstanding projections 234a from the wall 234. In some embodiments, an interior ledge 466 can form central openings 266a in the intermediate parts 250a, 250b for permitting fluid to flow in an inner column defined by the wall 234, as well as to receive any temperature sensor, dip tube or the like (which would be positioned after the fluid exits the fixed bed). In some embodiments, the second intermediate part 250b may be similarly constructed to promote interchangeability, in which case the openings (slots 264) in the second or upper intermediate part 250b allow for the creation of the thin falling flow or film of fluid within the fifth or return chamber 228, as previously noted.
[0046] In some embodiments, extending between the inner and outer walls 256, 258 are a plurality of supports 268. In some embodiments, the supports 268 include radially extending supports 268a and at least one circumferentially extending support 268b, which together can create a perforated or reticulated plate-like structure that allows fluid flow (which structure in this or any embodiment may comprise a screen, net, grid, or other skeletal structure, and may be rigid, semi-rigid, or flexible). In fact, the supports 268 may be designed to enhance fluid flow through the bed(s) by maximizing the amount of open space created by the openings for permitting fluid to pass. In some embodiments, for culturing cells, a fixed bed, such as the spiral bed (not shown) wound around wall 234 may be positioned in the chamber 224 formed between the parts 250a, 250b. In some embodiments, fluid passing from the upper intermediate part 250b can enters the fourth chamber 226 defined partially by cover part 270 and may flow to the column forming the fifth chamber 228 before returning to the first chamber 216 for recirculation.
[0047] In some embodiments, the cover part 270 includes a connector, such as tongue 272, for fitting into the corresponding connector (groove 254) of the second intermediate part 250b. In some embodiments, the cover part 270 can also include a first or central receiver, such as upstanding wall 274 for receiving a removable cap or lid 276, which may include various ports P for connecting with conduits for delivering fluids or other substances to the bioreactor 400 (and the fifth chamber 228). In some embodiments, the cap or lid 276 may also carry the temperature sensor or probe T, as shown, as well as other sensors, and may also be adapted for providing additions or removing substances from the bioreactor 200, or for regulating a product manufacturing process. As can be appreciated, in some embodiments, the cap or lid 276 can be well positioned to allow for sensing or fluid sampling to occur in connection with the return flow via chamber 228. In some embodiments, a second peripherally positioned receiver, such as upstanding wall 277, may also be adapted for connecting with a second cap or lid 278 for receiving sensors or depositing or withdrawing substances (including culture samples) from the bioreactor and, in particular, a peripheral portion thereof including the third chamber 226 in which cell culturing is completed. In some embodiments, the caps or lids 276, 278 may have different types of ports P and may be different sizes/shapes, or they may be identical to promote interchangeability.
[0048] In some embodiments, adhesives or glue may be used at the connections to hold the structures together. In some embodiments, threaded or locking (e.g., bayonet style) connections may also be used, such that a fluid-tight seal is maintained to prevent leakage and help ensure that sterility is maintained. In some embodiments, the arrangement of modular parts 230, 250, 270 allows for the bioreactor 200 to be pre-assembled, assembled or constructed on site rapidly, and potentially disassembled with similar rapidity. As it is possible to easily add additional tube(s) to form a heightened wall 234 or intermediate parts 250, the number of fixed beds or height of the bioreactor 200 may be adjusted to suit a particular need or process setting depending on the application.
[0049] In some embodiments, the flow from one fixed bed to the next-adjacent one in the chamber is direct or uninterrupted. In some embodiments, the outer chamber 224 for receiving the bed creates a continuous flow path through the multiple beds present therein, which may be structured fixed beds, unstructured fixed beds, or other beds. In some embodiments, the continuous and substantially unimpeded flow helps to promote homogeneity as if the modules are actually a single bed and thus improves the predictability and quality of the cell culturing process. Homogeneity means that the cell distribution throughout the bed is homogeneous or having a somewhat equal spread.
[0050]
[0051]
[0052] These figures also show that the intermediate parts 250 may engage internal tubes 236, which are fluid impervious to thus provide the chamber 228 for returning flow to the base part 230, where it may be agitated and returned to enter the beds from below and flow upwardly therethrough (in any embodiment disclosed). These tubes 236 may be provided such that one tube corresponds to each fixed bed 296 present, as shown, and two intermediate parts 250 engage each tube 236 (e.g., one from below and one from above). However, in this or any other disclosed embodiment, it should be appreciated that the innermost surface of the fixed bed, such as the innermost spiral wrap of a spiral bed, may be made to perform a similar function by making it or otherwise conditioning it so as to be impervious to fluid. For instance, the surface may be coated with a fluid-impervious or hydrophobic material, such that it still retains the fluid in the bed(s) and maintains a distinct, return flow of fluid through the central column formed by chamber 228.
[0053] According to a further aspect of the disclosure, a bioreactor (which could be any of the above-described bioreactors 100, 200, or any other known form) for processing the cells to generate a product of interest (e.g., a virus or protein) may be adapted to freeze the cells in the bed to a temperature below the freezing point of the liquid in the cells (e.g. from zero degrees down to −20° C., and more preferably within the range of about −5 to about −20 degrees Celsius) and then revert to an unfrozen state (e.g., to room temperature) afterwards, by thawing (including possibly with assisted heating). This temperature cycle causes the breaking of the cell membranes and the resulting release of the final product within the cells, thereby enhancing recovery of the product of interest. This process of recovery avoids any compromising of the integrity of the bioreactor. The bioreactor may be substantially drained of liquid prior to being subjected to freezing according to the disclosure in order to avoid damage to the bioreactor that might otherwise occur upon expansion of the frozen liquid, if completely filled, but could also be subjected to freezing during the draining of the liquid).
[0054] An embodiment of a bioreactor 300 is adapted to perform the above-described “freeze-thaw” operation without being placed inside of a freezer (which would be difficult, if not impossible, for most bioreactors in view of size constraints. Specifically, the bioreactor 300 may be connected directly to a freezer, the implementation of which may take various forms, as shown in
[0055] The jacket 390 may alternatively be in the form of a portable device or removable sleeve. This device or sleeve may slip over or snap around the bioreactor 300, and thus may be used when freezing is desired and not used otherwise. The sleeve can be pre-chilled/frozen, and may be reusable or made to be disposable
[0056] Causing the freezing of the liquid within the cells of the bioreactor 300 may be achieved in a variety of ways. One example is by providing a fluid (such as cold air) to the space covered by the jacket 390 (note inlet 392 and outlet 394 in
[0057] Another option, as shown in
[0058] Instead of a pipe(s) 396, the vessel may comprise a bladder, such as one or more flexible bags 398, as shown in
[0059] In any of these cases or others where the liquid in or around the cells is frozen, it may be allowed to thaw naturally by simply stopping the provision of chilled fluid to the jacket 390. Alternatively, a warming fluid may be supplied to the jacket 390 to assist with the thawing procedure. Still another alternative, and as discussed further below, is to use a heater to assist in the thawing operation for the frozen (or partially frozen) cells, which may involve adding a warm fluid or buffer to the jacket 390 or the bioreactor 300 itself.
[0060] Upon thawing, the cell membranes of the once-frozen cells are broken. Fluid such as buffer may be introduced to the bioreactor 300 to harvest the product or material of interest (e.g., a virus or protein). The bioreactor 300 may be at least partially drained of fluid before the freezing step, thereby creating room for additional fluid (i.e., the buffer, which again may be warmed to facilitate thawing). Once liquefied, the fluid may be pumped out of the bioreactor 300 to a holding tank and may be purified thereafter (either separate of combined with the thawed fluid).
[0061] According to another aspect of the disclosure, and referring to
[0062] If air is used as the medium for causing the cells to freeze, it may optionally be dehydrated so as to avoid having moisture condense and freeze in any delivery conduit and the sterilization filter 506, if present, and render both components unusable. Dehydrated air can be provided by drying ambient air using a dehydrator 510, as indicated, which make take the form of molecular sieves, a heat exchanger or other heat source, and which may be upstream or downstream of the freezer 502. Additionally, the air may be dried prior to delivery (before or after being chilled) by exposing it to coils or some other source at a temperature that is below the air target temperature of −20 degrees C., i.e. −30 degrees C. Instead of air, other gases could also be used.
[0063] As noted above, subsequent to freezing the cells, it may be desirable to subject the cells to thawing. This may be achieved passively or naturally by simply withdrawing any cold influence from an associated freezer or freezing means and waiting. However, it is also possible to subject the cells to active thawing, such as by warming or heating the cells or an associated portion or chamber of the bioreactor.
[0064] In some embodiments, active heating may be achieved using externally applied or transferred heat, and various examples of achieving such heating are shown in
[0065] As can be appreciated from
[0066] Referring to
[0067] This disclosure may also be considered to relate to a cell culturing bed with frozen cells, whether part of a bioreactor or otherwise.
[0068] As used herein, the following terms have the following meanings:
[0069] “A”, “an”, and “the” as used herein refers to both singular and plural referents unless the context clearly dictates otherwise. By way of example, “a compartment” refers to one or more than one compartment.
[0070] “About,” “substantially,” or “approximately,” as used herein referring to a measurable value, such as a parameter, an amount, a temporal duration, and the like, is meant to encompass variations of +/−20% or less, preferably +/−10% or less, more preferably +/−5% or less, even more 35 preferably +/−1% or less, and still more preferably +/−0.1% or less of and from the specified value, in so far such variations are appropriate to perform in the disclosed invention. However, it is to be understood that the value to which the modifier “about” refers is itself also specifically disclosed.
[0071] “Comprise”, “comprising”, and “comprises” and “comprised of” as used herein are synonymous with “include”, “including”, “includes” or “contain”, “containing”, “contains” and are inclusive or open-ended terms that specifies the presence of what follows e.g. component and do not exclude or preclude the presence of additional, non-recited components, features, element, members, steps, known in the art or disclosed therein.
[0072] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. For example, while the bioreactor is shown in a vertical orientation, it could be used in any orientation. Also, while the bioreactor is shown throughout independent of any isolator or cabinet, it should be understood that it could be used in combination with such structures in order to maintain a sterile environment. It should also be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the protection under the applicable law and that methods and structures within the scope of these claims and their equivalents be covered thereby.